Peter Lynch fit · Growth at a reasonable price (GARP)
Is ANI Pharmaceuticals, Inc. (ANIP) a Peter Lynch Stock?
Some GARP characteristics, but growth or valuation is stretched.
64/100
CSeñales mixtas
4/6 criterios cumplidos
Los criterios de Peter Lynch, aplicados a ANIP
PEG ≤ 1.0
clave-
EPS CAGR ≥ 15%
clave-
Revenue CAGR ≥ 10%
42.2%
Net margin > 0
8.6%
Cómo se valora ANIP en otras estrategias
Datos financieros en vivo
Cap. mercado
$1.88B
PER (TTM)
18.5x
ROIC (TTM)
8.17%
Margen bruto
65.94%
Otros análisis Peter Lynch
Preguntas frecuentes
What is ANIP's Peter Lynch fit score?
ANIP scores 64/100 on our Peter Lynch fit engine - grade C. Some GARP characteristics, but growth or valuation is stretched.
Does Peter Lynch actually own ANIP?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends ANIP.
How often is this score updated?
ANIP's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Peter Lynch posea o recomiende ANIP personalmente.